edatrexate has been researched along with Agranulocytosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beinart, GA; Booser, D; Broglio, K; Dhingra, K; Frye, D; Gonzalez-Angulo, AM; Gunale, S; Holmes, FA; Hortobagyi, GN; Rosenthal, J; Walters, R; Young, JA | 1 |
| Bready, B; Fueger, RH; Giannone, L; Levin, B; Lin, YG; Maldonado, A; Moore, DF; Pazdur, R; Winn, RJ | 1 |
| Armand, JP; Cappelaere, P; Clavel, M; Cognetti, F; de Graeff, A; de Mulder, PH; Schornagel, JH; Vermorken, JB; Verweij, J; Wildiers, J | 1 |
3 trial(s) available for edatrexate and Agranulocytosis
| Article | Year |
|---|---|
Phase II trial of 10-EDAM in the treatment of metastatic breast cancer.
Topics: Adult; Aged; Agranulocytosis; Alopecia; Aminopterin; Anemia; Antineoplastic Agents; Breast Neoplasms; Disease Progression; Female; Humans; Leukopenia; Middle Aged; Nausea; Survival Analysis; Time Factors; Treatment Outcome | 2007 |
Phase II trial of edatrexate in patients with advanced hepatocellular carcinoma.
Topics: Adult; Aged; Agranulocytosis; alpha-Fetoproteins; Aminopterin; Antineoplastic Agents; Carcinoma, Hepatocellular; Female; Folic Acid Antagonists; Humans; Liver Neoplasms; Male; Middle Aged; Remission Induction; Thrombocytopenia | 1994 |
Randomized phase III trial of edatrexate versus methotrexate in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck: a European Organization for Research and Treatment of Cancer Head and Neck Cancer Cooperative Group stu
Topics: Agranulocytosis; Aminopterin; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Injections, Intravenous; Lung; Male; Methotrexate; Respiratory Distress Syndrome; Thrombocytopenia | 1995 |